Disease progression and neuroscience
Copyright policy )Disease progression and neuroscience
The concepts of disease progression are discussed in the context of neurological disorders. The importance of understanding the time course of the response to inactive (placebo) treatment is discussed. Disease progression and response to placebo treatment both need to be considered before drug effects can be reliably identified. Criteria for distinguishing between symptomatic and disease modifying drug effects are proposed and used to interpret the results of clinical trials in pain, depression, schizophrenia, stroke, Alzheimer's disease and Parkinson's disease.
- University of Auckland New Zealand
Clinical Trials as Topic, Neuroprotective Agents, Treatment Outcome, Models, Neurological, Disease Progression, Neurosciences, Animals, Humans, Nervous System Diseases, Placebo Effect
Clinical Trials as Topic, Neuroprotective Agents, Treatment Outcome, Models, Neurological, Disease Progression, Neurosciences, Animals, Humans, Nervous System Diseases, Placebo Effect
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).7 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!